These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1880812)

  • 1. Calcium antagonists and cardiac noradrenaline release in ischemia.
    Richardt G; Haass M; Schömig A
    J Mol Cell Cardiol; 1991 Mar; 23(3):269-77. PubMed ID: 1880812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue.
    Kurz T; Richardt G; Hagl S; Seyfarth M; Schömig A
    J Mol Cell Cardiol; 1995 May; 27(5):1161-72. PubMed ID: 7473774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early intraneuronal mobilization and deamination of noradrenaline during global ischemia in the isolated perfused rat heart.
    Carlsson L; Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):508-18. PubMed ID: 3437922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements.
    Schömig A; Fischer S; Kurz T; Richardt G; Schömig E
    Circ Res; 1987 Feb; 60(2):194-205. PubMed ID: 3568291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia.
    Richardt G; Lumpp U; Haass M; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):50-5. PubMed ID: 2314483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular sodium and chloride depletion enhances nonexocytotic noradrenaline release induced by energy deficiency in rat heart.
    Kurz T; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):265-9. PubMed ID: 2812038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effect of nicotine on cardiac noradrenaline release during metabolic blockade.
    Richardt G; Brenn T; Seyfarth M; Haass M; Schömig E; Schömig A
    Basic Res Cardiol; 1994; 89(6):524-34. PubMed ID: 7702541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue.
    Kurz T; Richardt G; Seyfarth M; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):7-16. PubMed ID: 8832582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal sodium homoeostatis and axoplasmic amine concentration determine calcium-independent noradrenaline release in normoxic and ischemic rat heart.
    Schömig A; Kurz T; Richardt G; Schömig E
    Circ Res; 1988 Jul; 63(1):214-26. PubMed ID: 3383376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of digitalis glycosides on norepinephrine release in the heart. Dual mechanism of action.
    Kranzhöfer R; Haass M; Kurz T; Richardt G; Schömig A
    Circ Res; 1991 Jun; 68(6):1628-37. PubMed ID: 2036716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart.
    Haass M; Hock M; Richardt G; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):509-15. PubMed ID: 2615846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused hearts.
    Nayler WG; Sturrock WJ
    J Mol Cell Cardiol; 1984 Apr; 16(4):331-43. PubMed ID: 6726822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release.
    Schömig A; Dart AM; Dietz R; Mayer E; Kübler W
    Circ Res; 1984 Nov; 55(5):689-701. PubMed ID: 6488489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts.
    Kurz T; Offner B; Schreieck J; Richardt G; Tölg R; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):491-6. PubMed ID: 8751077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonism and norepinephrine release in myocardial ischemia.
    Schömig A; Rehmert G; Kurz T; Richardt G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S16-20. PubMed ID: 1284151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of calcium antagonists on the depletion of cardiac norepinephrine during postischemic reperfusion.
    Nayler WG; Sturrock WJ
    J Cardiovasc Pharmacol; 1985; 7(3):581-7. PubMed ID: 2410693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine.
    Grover GJ; Sleph PG
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):331-40. PubMed ID: 2476610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of verapamil, gallopamil, diltiazem and nifedipine on sarcoplasmic reticulum function in rat heart.
    Zucchi R; Limbruno U; Ronca-Testoni S; Yu G; Galbani P; Ronca G; Mariani M
    Cardioscience; 1992 Sep; 3(3):167-72. PubMed ID: 1330045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of cardiac noradrenaline stores by the calcium-channel blocker D-600.
    Chaudhry A; Vohra MM
    Can J Physiol Pharmacol; 1984 Jun; 62(6):640-4. PubMed ID: 6744107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of gallopamil against ischemia and reperfusion damage.
    Ferrari R; Boraso A; Condorelli E; De Giuli F; Pasini E; Cargnoni A; Agnoletti G; Ghielmi S
    Z Kardiol; 1989; 78 Suppl 5():1-11. PubMed ID: 2631474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.